Sangamo Therapeutics Inc. (NASDAQ:SGMO) went down by -9.48% from its latest closing price compared to the recent 1-year high of $11.49. The company’s stock price has collected -7.89% of loss in the last five trading sessions.
Is It Worth Investing in Sangamo Therapeutics Inc. (NASDAQ :SGMO) Right Now?
Plus, the 36-month beta value for SGMO is at 1.29.
SGMO currently public float of 131.75M and currently shorts hold a 6.70% ratio of that float. Today, the average trading volume of SGMO was 1.62M shares.
SGMO’s Market Performance
SGMO stocks went down by -7.89% for the week, with a monthly drop of -10.87% and a quarterly performance of 58.13%, while its annual performance rate touched -43.12%. The volatility ratio for the week stands at 5.67% while the volatility levels for the past 30 days are set at 5.51% for Sangamo Therapeutics Inc. The simple moving average for the period of the last 20 days is -6.23% for SGMO stocks with a simple moving average of -4.13% for the last 200 days.
Analysts’ Opinion of SGMO
Many brokerage firms have already submitted their reports for SGMO stocks, with Wedbush repeating the rating for SGMO by listing it as a “Neutral.” The predicted price for SGMO in the upcoming period, according to Wedbush is $5 based on the research report published on June 13th of the current year 2022.
RBC Capital Mkts, on the other hand, stated in their research note that they expect to see SGMO reach a price target of $22. The rating they have provided for SGMO stocks is “Outperform” according to the report published on May 04th, 2021.
Guggenheim gave a rating of “Neutral” to SGMO, setting the target price at $16 in the report published on January 07th of the previous year.
SGMO Trading at 1.14% from the 50-Day Moving Average
After a stumble in the market that brought SGMO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -54.31% of loss for the given period.
Volatility was left at 5.51%, however, over the last 30 days, the volatility rate increased by 5.67%, as shares sank -12.06% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +12.42% upper at present.
During the last 5 trading sessions, SGMO fell by -7.89%, which changed the moving average for the period of 200-days by -36.67% in comparison to the 20-day moving average, which settled at $5.56. In addition, Sangamo Therapeutics Inc. saw -30.00% in overturn over a single year, with a tendency to cut further losses.
Reports are indicating that there were more than several insider trading activities at SGMO starting from BIOGEN INC., who sale 100,000 shares at the price of $5.27 back on Aug 30. After this action, BIOGEN INC. now owns 23,652,466 shares of Sangamo Therapeutics Inc., valued at $526,520 using the latest closing price.
BIOGEN INC., the 10% Owner of Sangamo Therapeutics Inc., sale 400,000 shares at $5.33 during a trade that took place back on Aug 29, which means that BIOGEN INC. is holding 23,752,466 shares at $2,130,720 based on the most recent closing price.
Stock Fundamentals for SGMO
Current profitability levels for the company are sitting at:
- -165.61 for the present operating margin
- +91.47 for the gross margin
The net margin for Sangamo Therapeutics Inc. stands at -161.05. Equity return is now at value -48.10, with -24.90 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 3.12.